Global Cannabis Based Medicines Market Research Report 2025(Status and Outlook)
Cannabis-based medicines are pharmaceutical products derived from the cannabis plant or synthetic cannabinoids, designed for therapeutic use to treat specific medical conditions such as chronic pain, epilepsy, multiple sclerosis-related spasticity, chemotherapy-induced nausea and vomiting, and certain psychiatric disorders; these medicines are standardized in composition, dosage, and delivery forms?such as oral solutions, capsules, sprays, or oils?and are subject to rigorous regulatory approval processes to ensure safety, efficacy, and quality control, distinguishing them from recreational or unregulated cannabis products. The global market for cannabis-based medicines has expanded significantly, driven by increasing legalization for medical use, growing clinical evidence supporting their efficacy, and rising patient demand for alternative treatment options, with key products including cannabidiol (CBD)-based medications like Epidiolex and nabiximols (Sativex), as well as dronabinol and nabilone; market growth is further fueled by investments in research and development, strategic partnerships between pharmaceutical companies and cannabis producers, and evolving regulatory frameworks that are gradually recognizing the medical value of cannabinoids, though challenges such as varying international regulations, stigma, high costs, and limited insurance coverage in some regions persist. North America and Europe currently dominate the market due to progressive legislation and established healthcare infrastructure, while emerging markets in Asia-Pacific and Latin America show potential for growth as regulatory barriers ease and awareness increases.
The global Cannabis Based Medicines market size was estimated at USD 2678.4 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 18.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cannabis Based Medicines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cannabis Based Medicines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cannabis Based Medicines market.
Global Cannabis Based Medicines Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
GW Pharmaceuticals plc
INSYS Therapeutics
Aequus Pharmaceuticals
Axim Biotechnologies
Revive Therapeutics
MGC Pharmaceuticals
ECHO Pharmaceuticals
Market Segmentation (by Type)
CBD (Cannabidiol) Based
THC (Tetrahydrocannabinol) Based
Others
Market Segmentation (by Application)
Oral Solution
Tablets
Patches
Others
Geographic Segmentation
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cannabis Based Medicines Market
Overview of the regional outlook of the Cannabis Based Medicines Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cannabis Based Medicines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cannabis Based Medicines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Cannabis Based Medicines market size was estimated at USD 2678.4 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 18.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cannabis Based Medicines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cannabis Based Medicines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cannabis Based Medicines market.
Global Cannabis Based Medicines Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
GW Pharmaceuticals plc
INSYS Therapeutics
Aequus Pharmaceuticals
Axim Biotechnologies
Revive Therapeutics
MGC Pharmaceuticals
ECHO Pharmaceuticals
Market Segmentation (by Type)
CBD (Cannabidiol) Based
THC (Tetrahydrocannabinol) Based
Others
Market Segmentation (by Application)
Oral Solution
Tablets
Patches
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Cannabis Based Medicines Market
Overview of the regional outlook of the Cannabis Based Medicines Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cannabis Based Medicines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cannabis Based Medicines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Cannabis Based Medicines
1.2 Key Market Segments
1.2.1 Cannabis Based Medicines Segment by Type
1.2.2 Cannabis Based Medicines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CANNABIS BASED MEDICINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cannabis Based Medicines Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Cannabis Based Medicines Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CANNABIS BASED MEDICINES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cannabis Based Medicines Product Life Cycle
3.3 Global Cannabis Based Medicines Sales by Manufacturers (2020-2025)
3.4 Global Cannabis Based Medicines Revenue Market Share by Manufacturers (2020-2025)
3.5 Cannabis Based Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cannabis Based Medicines Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Cannabis Based Medicines Market Competitive Situation and Trends
3.8.1 Cannabis Based Medicines Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cannabis Based Medicines Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CANNABIS BASED MEDICINES INDUSTRY CHAIN ANALYSIS
4.1 Cannabis Based Medicines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CANNABIS BASED MEDICINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cannabis Based Medicines Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cannabis Based Medicines Market
5.7 ESG Ratings of Leading Companies
6 CANNABIS BASED MEDICINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cannabis Based Medicines Sales Market Share by Type (2020-2025)
6.3 Global Cannabis Based Medicines Market Size Market Share by Type (2020-2025)
6.4 Global Cannabis Based Medicines Price by Type (2020-2025)
7 CANNABIS BASED MEDICINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cannabis Based Medicines Market Sales by Application (2020-2025)
7.3 Global Cannabis Based Medicines Market Size (M USD) by Application (2020-2025)
7.4 Global Cannabis Based Medicines Sales Growth Rate by Application (2020-2025)
8 CANNABIS BASED MEDICINES MARKET SALES BY REGION
8.1 Global Cannabis Based Medicines Sales by Region
8.1.1 Global Cannabis Based Medicines Sales by Region
8.1.2 Global Cannabis Based Medicines Sales Market Share by Region
8.2 Global Cannabis Based Medicines Market Size by Region
8.2.1 Global Cannabis Based Medicines Market Size by Region
8.2.2 Global Cannabis Based Medicines Market Size Market Share by Region
8.3 North America
8.3.1 North America Cannabis Based Medicines Sales by Country
8.3.2 North America Cannabis Based Medicines Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cannabis Based Medicines Sales by Country
8.4.2 Europe Cannabis Based Medicines Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cannabis Based Medicines Sales by Region
8.5.2 Asia Pacific Cannabis Based Medicines Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cannabis Based Medicines Sales by Country
8.6.2 South America Cannabis Based Medicines Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cannabis Based Medicines Sales by Region
8.7.2 Middle East and Africa Cannabis Based Medicines Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CANNABIS BASED MEDICINES MARKET PRODUCTION BY REGION
9.1 Global Production of Cannabis Based Medicines by Region(2020-2025)
9.2 Global Cannabis Based Medicines Revenue Market Share by Region (2020-2025)
9.3 Global Cannabis Based Medicines Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cannabis Based Medicines Production
9.4.1 North America Cannabis Based Medicines Production Growth Rate (2020-2025)
9.4.2 North America Cannabis Based Medicines Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cannabis Based Medicines Production
9.5.1 Europe Cannabis Based Medicines Production Growth Rate (2020-2025)
9.5.2 Europe Cannabis Based Medicines Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cannabis Based Medicines Production (2020-2025)
9.6.1 Japan Cannabis Based Medicines Production Growth Rate (2020-2025)
9.6.2 Japan Cannabis Based Medicines Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cannabis Based Medicines Production (2020-2025)
9.7.1 China Cannabis Based Medicines Production Growth Rate (2020-2025)
9.7.2 China Cannabis Based Medicines Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 GW Pharmaceuticals plc
10.1.1 GW Pharmaceuticals plc Basic Information
10.1.2 GW Pharmaceuticals plc Cannabis Based Medicines Product Overview
10.1.3 GW Pharmaceuticals plc Cannabis Based Medicines Product Market Performance
10.1.4 GW Pharmaceuticals plc Business Overview
10.1.5 GW Pharmaceuticals plc SWOT Analysis
10.1.6 GW Pharmaceuticals plc Recent Developments
10.2 INSYS Therapeutics
10.2.1 INSYS Therapeutics Basic Information
10.2.2 INSYS Therapeutics Cannabis Based Medicines Product Overview
10.2.3 INSYS Therapeutics Cannabis Based Medicines Product Market Performance
10.2.4 INSYS Therapeutics Business Overview
10.2.5 INSYS Therapeutics SWOT Analysis
10.2.6 INSYS Therapeutics Recent Developments
10.3 Aequus Pharmaceuticals
10.3.1 Aequus Pharmaceuticals Basic Information
10.3.2 Aequus Pharmaceuticals Cannabis Based Medicines Product Overview
10.3.3 Aequus Pharmaceuticals Cannabis Based Medicines Product Market Performance
10.3.4 Aequus Pharmaceuticals Business Overview
10.3.5 Aequus Pharmaceuticals SWOT Analysis
10.3.6 Aequus Pharmaceuticals Recent Developments
10.4 Axim Biotechnologies
10.4.1 Axim Biotechnologies Basic Information
10.4.2 Axim Biotechnologies Cannabis Based Medicines Product Overview
10.4.3 Axim Biotechnologies Cannabis Based Medicines Product Market Performance
10.4.4 Axim Biotechnologies Business Overview
10.4.5 Axim Biotechnologies Recent Developments
10.5 Revive Therapeutics
10.5.1 Revive Therapeutics Basic Information
10.5.2 Revive Therapeutics Cannabis Based Medicines Product Overview
10.5.3 Revive Therapeutics Cannabis Based Medicines Product Market Performance
10.5.4 Revive Therapeutics Business Overview
10.5.5 Revive Therapeutics Recent Developments
10.6 MGC Pharmaceuticals
10.6.1 MGC Pharmaceuticals Basic Information
10.6.2 MGC Pharmaceuticals Cannabis Based Medicines Product Overview
10.6.3 MGC Pharmaceuticals Cannabis Based Medicines Product Market Performance
10.6.4 MGC Pharmaceuticals Business Overview
10.6.5 MGC Pharmaceuticals Recent Developments
10.7 ECHO Pharmaceuticals
10.7.1 ECHO Pharmaceuticals Basic Information
10.7.2 ECHO Pharmaceuticals Cannabis Based Medicines Product Overview
10.7.3 ECHO Pharmaceuticals Cannabis Based Medicines Product Market Performance
10.7.4 ECHO Pharmaceuticals Business Overview
10.7.5 ECHO Pharmaceuticals Recent Developments
11 CANNABIS BASED MEDICINES MARKET FORECAST BY REGION
11.1 Global Cannabis Based Medicines Market Size Forecast
11.2 Global Cannabis Based Medicines Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cannabis Based Medicines Market Size Forecast by Country
11.2.3 Asia Pacific Cannabis Based Medicines Market Size Forecast by Region
11.2.4 South America Cannabis Based Medicines Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cannabis Based Medicines by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Cannabis Based Medicines Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Cannabis Based Medicines by Type (2026-2033)
12.1.2 Global Cannabis Based Medicines Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Cannabis Based Medicines by Type (2026-2033)
12.2 Global Cannabis Based Medicines Market Forecast by Application (2026-2033)
12.2.1 Global Cannabis Based Medicines Sales (K Units) Forecast by Application
12.2.2 Global Cannabis Based Medicines Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Cannabis Based Medicines
1.2 Key Market Segments
1.2.1 Cannabis Based Medicines Segment by Type
1.2.2 Cannabis Based Medicines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CANNABIS BASED MEDICINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cannabis Based Medicines Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Cannabis Based Medicines Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CANNABIS BASED MEDICINES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cannabis Based Medicines Product Life Cycle
3.3 Global Cannabis Based Medicines Sales by Manufacturers (2020-2025)
3.4 Global Cannabis Based Medicines Revenue Market Share by Manufacturers (2020-2025)
3.5 Cannabis Based Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cannabis Based Medicines Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Cannabis Based Medicines Market Competitive Situation and Trends
3.8.1 Cannabis Based Medicines Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cannabis Based Medicines Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CANNABIS BASED MEDICINES INDUSTRY CHAIN ANALYSIS
4.1 Cannabis Based Medicines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CANNABIS BASED MEDICINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cannabis Based Medicines Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Cannabis Based Medicines Market
5.7 ESG Ratings of Leading Companies
6 CANNABIS BASED MEDICINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cannabis Based Medicines Sales Market Share by Type (2020-2025)
6.3 Global Cannabis Based Medicines Market Size Market Share by Type (2020-2025)
6.4 Global Cannabis Based Medicines Price by Type (2020-2025)
7 CANNABIS BASED MEDICINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cannabis Based Medicines Market Sales by Application (2020-2025)
7.3 Global Cannabis Based Medicines Market Size (M USD) by Application (2020-2025)
7.4 Global Cannabis Based Medicines Sales Growth Rate by Application (2020-2025)
8 CANNABIS BASED MEDICINES MARKET SALES BY REGION
8.1 Global Cannabis Based Medicines Sales by Region
8.1.1 Global Cannabis Based Medicines Sales by Region
8.1.2 Global Cannabis Based Medicines Sales Market Share by Region
8.2 Global Cannabis Based Medicines Market Size by Region
8.2.1 Global Cannabis Based Medicines Market Size by Region
8.2.2 Global Cannabis Based Medicines Market Size Market Share by Region
8.3 North America
8.3.1 North America Cannabis Based Medicines Sales by Country
8.3.2 North America Cannabis Based Medicines Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Cannabis Based Medicines Sales by Country
8.4.2 Europe Cannabis Based Medicines Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Cannabis Based Medicines Sales by Region
8.5.2 Asia Pacific Cannabis Based Medicines Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Cannabis Based Medicines Sales by Country
8.6.2 South America Cannabis Based Medicines Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Cannabis Based Medicines Sales by Region
8.7.2 Middle East and Africa Cannabis Based Medicines Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CANNABIS BASED MEDICINES MARKET PRODUCTION BY REGION
9.1 Global Production of Cannabis Based Medicines by Region(2020-2025)
9.2 Global Cannabis Based Medicines Revenue Market Share by Region (2020-2025)
9.3 Global Cannabis Based Medicines Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Cannabis Based Medicines Production
9.4.1 North America Cannabis Based Medicines Production Growth Rate (2020-2025)
9.4.2 North America Cannabis Based Medicines Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Cannabis Based Medicines Production
9.5.1 Europe Cannabis Based Medicines Production Growth Rate (2020-2025)
9.5.2 Europe Cannabis Based Medicines Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Cannabis Based Medicines Production (2020-2025)
9.6.1 Japan Cannabis Based Medicines Production Growth Rate (2020-2025)
9.6.2 Japan Cannabis Based Medicines Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Cannabis Based Medicines Production (2020-2025)
9.7.1 China Cannabis Based Medicines Production Growth Rate (2020-2025)
9.7.2 China Cannabis Based Medicines Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 GW Pharmaceuticals plc
10.1.1 GW Pharmaceuticals plc Basic Information
10.1.2 GW Pharmaceuticals plc Cannabis Based Medicines Product Overview
10.1.3 GW Pharmaceuticals plc Cannabis Based Medicines Product Market Performance
10.1.4 GW Pharmaceuticals plc Business Overview
10.1.5 GW Pharmaceuticals plc SWOT Analysis
10.1.6 GW Pharmaceuticals plc Recent Developments
10.2 INSYS Therapeutics
10.2.1 INSYS Therapeutics Basic Information
10.2.2 INSYS Therapeutics Cannabis Based Medicines Product Overview
10.2.3 INSYS Therapeutics Cannabis Based Medicines Product Market Performance
10.2.4 INSYS Therapeutics Business Overview
10.2.5 INSYS Therapeutics SWOT Analysis
10.2.6 INSYS Therapeutics Recent Developments
10.3 Aequus Pharmaceuticals
10.3.1 Aequus Pharmaceuticals Basic Information
10.3.2 Aequus Pharmaceuticals Cannabis Based Medicines Product Overview
10.3.3 Aequus Pharmaceuticals Cannabis Based Medicines Product Market Performance
10.3.4 Aequus Pharmaceuticals Business Overview
10.3.5 Aequus Pharmaceuticals SWOT Analysis
10.3.6 Aequus Pharmaceuticals Recent Developments
10.4 Axim Biotechnologies
10.4.1 Axim Biotechnologies Basic Information
10.4.2 Axim Biotechnologies Cannabis Based Medicines Product Overview
10.4.3 Axim Biotechnologies Cannabis Based Medicines Product Market Performance
10.4.4 Axim Biotechnologies Business Overview
10.4.5 Axim Biotechnologies Recent Developments
10.5 Revive Therapeutics
10.5.1 Revive Therapeutics Basic Information
10.5.2 Revive Therapeutics Cannabis Based Medicines Product Overview
10.5.3 Revive Therapeutics Cannabis Based Medicines Product Market Performance
10.5.4 Revive Therapeutics Business Overview
10.5.5 Revive Therapeutics Recent Developments
10.6 MGC Pharmaceuticals
10.6.1 MGC Pharmaceuticals Basic Information
10.6.2 MGC Pharmaceuticals Cannabis Based Medicines Product Overview
10.6.3 MGC Pharmaceuticals Cannabis Based Medicines Product Market Performance
10.6.4 MGC Pharmaceuticals Business Overview
10.6.5 MGC Pharmaceuticals Recent Developments
10.7 ECHO Pharmaceuticals
10.7.1 ECHO Pharmaceuticals Basic Information
10.7.2 ECHO Pharmaceuticals Cannabis Based Medicines Product Overview
10.7.3 ECHO Pharmaceuticals Cannabis Based Medicines Product Market Performance
10.7.4 ECHO Pharmaceuticals Business Overview
10.7.5 ECHO Pharmaceuticals Recent Developments
11 CANNABIS BASED MEDICINES MARKET FORECAST BY REGION
11.1 Global Cannabis Based Medicines Market Size Forecast
11.2 Global Cannabis Based Medicines Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Cannabis Based Medicines Market Size Forecast by Country
11.2.3 Asia Pacific Cannabis Based Medicines Market Size Forecast by Region
11.2.4 South America Cannabis Based Medicines Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Cannabis Based Medicines by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Cannabis Based Medicines Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Cannabis Based Medicines by Type (2026-2033)
12.1.2 Global Cannabis Based Medicines Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Cannabis Based Medicines by Type (2026-2033)
12.2 Global Cannabis Based Medicines Market Forecast by Application (2026-2033)
12.2.1 Global Cannabis Based Medicines Sales (K Units) Forecast by Application
12.2.2 Global Cannabis Based Medicines Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cannabis Based Medicines Market Size Comparison by Region (M USD)
Table 5. Global Cannabis Based Medicines Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Cannabis Based Medicines Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Cannabis Based Medicines Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Cannabis Based Medicines Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabis Based Medicines as of 2024)
Table 10. Global Market Cannabis Based Medicines Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Cannabis Based Medicines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Cannabis Based Medicines Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Cannabis Based Medicines Sales by Type (K Units)
Table 26. Global Cannabis Based Medicines Market Size by Type (M USD)
Table 27. Global Cannabis Based Medicines Sales (K Units) by Type (2020-2025)
Table 28. Global Cannabis Based Medicines Sales Market Share by Type (2020-2025)
Table 29. Global Cannabis Based Medicines Market Size (M USD) by Type (2020-2025)
Table 30. Global Cannabis Based Medicines Market Size Share by Type (2020-2025)
Table 31. Global Cannabis Based Medicines Price (USD/Unit) by Type (2020-2025)
Table 32. Global Cannabis Based Medicines Sales (K Units) by Application
Table 33. Global Cannabis Based Medicines Market Size by Application
Table 34. Global Cannabis Based Medicines Sales by Application (2020-2025) & (K Units)
Table 35. Global Cannabis Based Medicines Sales Market Share by Application (2020-2025)
Table 36. Global Cannabis Based Medicines Market Size by Application (2020-2025) & (M USD)
Table 37. Global Cannabis Based Medicines Market Share by Application (2020-2025)
Table 38. Global Cannabis Based Medicines Sales Growth Rate by Application (2020-2025)
Table 39. Global Cannabis Based Medicines Sales by Region (2020-2025) & (K Units)
Table 40. Global Cannabis Based Medicines Sales Market Share by Region (2020-2025)
Table 41. Global Cannabis Based Medicines Market Size by Region (2020-2025) & (M USD)
Table 42. Global Cannabis Based Medicines Market Size Market Share by Region (2020-2025)
Table 43. North America Cannabis Based Medicines Sales by Country (2020-2025) & (K Units)
Table 44. North America Cannabis Based Medicines Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Cannabis Based Medicines Sales by Country (2020-2025) & (K Units)
Table 46. Europe Cannabis Based Medicines Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Cannabis Based Medicines Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Cannabis Based Medicines Market Size by Region (2020-2025) & (M USD)
Table 49. South America Cannabis Based Medicines Sales by Country (2020-2025) & (K Units)
Table 50. South America Cannabis Based Medicines Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Cannabis Based Medicines Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Cannabis Based Medicines Market Size by Region (2020-2025) & (M USD)
Table 53. Global Cannabis Based Medicines Production (K Units) by Region(2020-2025)
Table 54. Global Cannabis Based Medicines Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Cannabis Based Medicines Revenue Market Share by Region (2020-2025)
Table 56. Global Cannabis Based Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Cannabis Based Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Cannabis Based Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Cannabis Based Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Cannabis Based Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. GW Pharmaceuticals plc Basic Information
Table 62. GW Pharmaceuticals plc Cannabis Based Medicines Product Overview
Table 63. GW Pharmaceuticals plc Cannabis Based Medicines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. GW Pharmaceuticals plc Business Overview
Table 65. GW Pharmaceuticals plc SWOT Analysis
Table 66. GW Pharmaceuticals plc Recent Developments
Table 67. INSYS Therapeutics Basic Information
Table 68. INSYS Therapeutics Cannabis Based Medicines Product Overview
Table 69. INSYS Therapeutics Cannabis Based Medicines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. INSYS Therapeutics Business Overview
Table 71. INSYS Therapeutics SWOT Analysis
Table 72. INSYS Therapeutics Recent Developments
Table 73. Aequus Pharmaceuticals Basic Information
Table 74. Aequus Pharmaceuticals Cannabis Based Medicines Product Overview
Table 75. Aequus Pharmaceuticals Cannabis Based Medicines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Aequus Pharmaceuticals Business Overview
Table 77. Aequus Pharmaceuticals SWOT Analysis
Table 78. Aequus Pharmaceuticals Recent Developments
Table 79. Axim Biotechnologies Basic Information
Table 80. Axim Biotechnologies Cannabis Based Medicines Product Overview
Table 81. Axim Biotechnologies Cannabis Based Medicines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Axim Biotechnologies Business Overview
Table 83. Axim Biotechnologies Recent Developments
Table 84. Revive Therapeutics Basic Information
Table 85. Revive Therapeutics Cannabis Based Medicines Product Overview
Table 86. Revive Therapeutics Cannabis Based Medicines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Revive Therapeutics Business Overview
Table 88. Revive Therapeutics Recent Developments
Table 89. MGC Pharmaceuticals Basic Information
Table 90. MGC Pharmaceuticals Cannabis Based Medicines Product Overview
Table 91. MGC Pharmaceuticals Cannabis Based Medicines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. MGC Pharmaceuticals Business Overview
Table 93. MGC Pharmaceuticals Recent Developments
Table 94. ECHO Pharmaceuticals Basic Information
Table 95. ECHO Pharmaceuticals Cannabis Based Medicines Product Overview
Table 96. ECHO Pharmaceuticals Cannabis Based Medicines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. ECHO Pharmaceuticals Business Overview
Table 98. ECHO Pharmaceuticals Recent Developments
Table 99. Global Cannabis Based Medicines Sales Forecast by Region (2026-2033) & (K Units)
Table 100. Global Cannabis Based Medicines Market Size Forecast by Region (2026-2033) & (M USD)
Table 101. North America Cannabis Based Medicines Sales Forecast by Country (2026-2033) & (K Units)
Table 102. North America Cannabis Based Medicines Market Size Forecast by Country (2026-2033) & (M USD)
Table 103. Europe Cannabis Based Medicines Sales Forecast by Country (2026-2033) & (K Units)
Table 104. Europe Cannabis Based Medicines Market Size Forecast by Country (2026-2033) & (M USD)
Table 105. Asia Pacific Cannabis Based Medicines Sales Forecast by Region (2026-2033) & (K Units)
Table 106. Asia Pacific Cannabis Based Medicines Market Size Forecast by Region (2026-2033) & (M USD)
Table 107. South America Cannabis Based Medicines Sales Forecast by Country (2026-2033) & (K Units)
Table 108. South America Cannabis Based Medicines Market Size Forecast by Country (2026-2033) & (M USD)
Table 109. Middle East and Africa Cannabis Based Medicines Sales Forecast by Country (2026-2033) & (Units)
Table 110. Middle East and Africa Cannabis Based Medicines Market Size Forecast by Country (2026-2033) & (M USD)
Table 111. Global Cannabis Based Medicines Sales Forecast by Type (2026-2033) & (K Units)
Table 112. Global Cannabis Based Medicines Market Size Forecast by Type (2026-2033) & (M USD)
Table 113. Global Cannabis Based Medicines Price Forecast by Type (2026-2033) & (USD/Unit)
Table 114. Global Cannabis Based Medicines Sales (K Units) Forecast by Application (2026-2033)
Table 115. Global Cannabis Based Medicines Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cannabis Based Medicines Market Size Comparison by Region (M USD)
Table 5. Global Cannabis Based Medicines Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Cannabis Based Medicines Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Cannabis Based Medicines Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Cannabis Based Medicines Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabis Based Medicines as of 2024)
Table 10. Global Market Cannabis Based Medicines Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Cannabis Based Medicines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Cannabis Based Medicines Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Cannabis Based Medicines Sales by Type (K Units)
Table 26. Global Cannabis Based Medicines Market Size by Type (M USD)
Table 27. Global Cannabis Based Medicines Sales (K Units) by Type (2020-2025)
Table 28. Global Cannabis Based Medicines Sales Market Share by Type (2020-2025)
Table 29. Global Cannabis Based Medicines Market Size (M USD) by Type (2020-2025)
Table 30. Global Cannabis Based Medicines Market Size Share by Type (2020-2025)
Table 31. Global Cannabis Based Medicines Price (USD/Unit) by Type (2020-2025)
Table 32. Global Cannabis Based Medicines Sales (K Units) by Application
Table 33. Global Cannabis Based Medicines Market Size by Application
Table 34. Global Cannabis Based Medicines Sales by Application (2020-2025) & (K Units)
Table 35. Global Cannabis Based Medicines Sales Market Share by Application (2020-2025)
Table 36. Global Cannabis Based Medicines Market Size by Application (2020-2025) & (M USD)
Table 37. Global Cannabis Based Medicines Market Share by Application (2020-2025)
Table 38. Global Cannabis Based Medicines Sales Growth Rate by Application (2020-2025)
Table 39. Global Cannabis Based Medicines Sales by Region (2020-2025) & (K Units)
Table 40. Global Cannabis Based Medicines Sales Market Share by Region (2020-2025)
Table 41. Global Cannabis Based Medicines Market Size by Region (2020-2025) & (M USD)
Table 42. Global Cannabis Based Medicines Market Size Market Share by Region (2020-2025)
Table 43. North America Cannabis Based Medicines Sales by Country (2020-2025) & (K Units)
Table 44. North America Cannabis Based Medicines Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Cannabis Based Medicines Sales by Country (2020-2025) & (K Units)
Table 46. Europe Cannabis Based Medicines Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Cannabis Based Medicines Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Cannabis Based Medicines Market Size by Region (2020-2025) & (M USD)
Table 49. South America Cannabis Based Medicines Sales by Country (2020-2025) & (K Units)
Table 50. South America Cannabis Based Medicines Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Cannabis Based Medicines Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Cannabis Based Medicines Market Size by Region (2020-2025) & (M USD)
Table 53. Global Cannabis Based Medicines Production (K Units) by Region(2020-2025)
Table 54. Global Cannabis Based Medicines Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Cannabis Based Medicines Revenue Market Share by Region (2020-2025)
Table 56. Global Cannabis Based Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Cannabis Based Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Cannabis Based Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Cannabis Based Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Cannabis Based Medicines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. GW Pharmaceuticals plc Basic Information
Table 62. GW Pharmaceuticals plc Cannabis Based Medicines Product Overview
Table 63. GW Pharmaceuticals plc Cannabis Based Medicines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. GW Pharmaceuticals plc Business Overview
Table 65. GW Pharmaceuticals plc SWOT Analysis
Table 66. GW Pharmaceuticals plc Recent Developments
Table 67. INSYS Therapeutics Basic Information
Table 68. INSYS Therapeutics Cannabis Based Medicines Product Overview
Table 69. INSYS Therapeutics Cannabis Based Medicines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. INSYS Therapeutics Business Overview
Table 71. INSYS Therapeutics SWOT Analysis
Table 72. INSYS Therapeutics Recent Developments
Table 73. Aequus Pharmaceuticals Basic Information
Table 74. Aequus Pharmaceuticals Cannabis Based Medicines Product Overview
Table 75. Aequus Pharmaceuticals Cannabis Based Medicines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Aequus Pharmaceuticals Business Overview
Table 77. Aequus Pharmaceuticals SWOT Analysis
Table 78. Aequus Pharmaceuticals Recent Developments
Table 79. Axim Biotechnologies Basic Information
Table 80. Axim Biotechnologies Cannabis Based Medicines Product Overview
Table 81. Axim Biotechnologies Cannabis Based Medicines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Axim Biotechnologies Business Overview
Table 83. Axim Biotechnologies Recent Developments
Table 84. Revive Therapeutics Basic Information
Table 85. Revive Therapeutics Cannabis Based Medicines Product Overview
Table 86. Revive Therapeutics Cannabis Based Medicines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Revive Therapeutics Business Overview
Table 88. Revive Therapeutics Recent Developments
Table 89. MGC Pharmaceuticals Basic Information
Table 90. MGC Pharmaceuticals Cannabis Based Medicines Product Overview
Table 91. MGC Pharmaceuticals Cannabis Based Medicines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. MGC Pharmaceuticals Business Overview
Table 93. MGC Pharmaceuticals Recent Developments
Table 94. ECHO Pharmaceuticals Basic Information
Table 95. ECHO Pharmaceuticals Cannabis Based Medicines Product Overview
Table 96. ECHO Pharmaceuticals Cannabis Based Medicines Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. ECHO Pharmaceuticals Business Overview
Table 98. ECHO Pharmaceuticals Recent Developments
Table 99. Global Cannabis Based Medicines Sales Forecast by Region (2026-2033) & (K Units)
Table 100. Global Cannabis Based Medicines Market Size Forecast by Region (2026-2033) & (M USD)
Table 101. North America Cannabis Based Medicines Sales Forecast by Country (2026-2033) & (K Units)
Table 102. North America Cannabis Based Medicines Market Size Forecast by Country (2026-2033) & (M USD)
Table 103. Europe Cannabis Based Medicines Sales Forecast by Country (2026-2033) & (K Units)
Table 104. Europe Cannabis Based Medicines Market Size Forecast by Country (2026-2033) & (M USD)
Table 105. Asia Pacific Cannabis Based Medicines Sales Forecast by Region (2026-2033) & (K Units)
Table 106. Asia Pacific Cannabis Based Medicines Market Size Forecast by Region (2026-2033) & (M USD)
Table 107. South America Cannabis Based Medicines Sales Forecast by Country (2026-2033) & (K Units)
Table 108. South America Cannabis Based Medicines Market Size Forecast by Country (2026-2033) & (M USD)
Table 109. Middle East and Africa Cannabis Based Medicines Sales Forecast by Country (2026-2033) & (Units)
Table 110. Middle East and Africa Cannabis Based Medicines Market Size Forecast by Country (2026-2033) & (M USD)
Table 111. Global Cannabis Based Medicines Sales Forecast by Type (2026-2033) & (K Units)
Table 112. Global Cannabis Based Medicines Market Size Forecast by Type (2026-2033) & (M USD)
Table 113. Global Cannabis Based Medicines Price Forecast by Type (2026-2033) & (USD/Unit)
Table 114. Global Cannabis Based Medicines Sales (K Units) Forecast by Application (2026-2033)
Table 115. Global Cannabis Based Medicines Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Cannabis Based Medicines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cannabis Based Medicines Market Size (M USD), 2024-2033
Figure 5. Global Cannabis Based Medicines Market Size (M USD) (2020-2033)
Figure 6. Global Cannabis Based Medicines Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cannabis Based Medicines Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cannabis Based Medicines Product Life Cycle
Figure 13. Cannabis Based Medicines Sales Share by Manufacturers in 2024
Figure 14. Global Cannabis Based Medicines Revenue Share by Manufacturers in 2024
Figure 15. Cannabis Based Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Cannabis Based Medicines Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cannabis Based Medicines Revenue in 2024
Figure 18. Industry Chain Map of Cannabis Based Medicines
Figure 19. Global Cannabis Based Medicines Market PEST Analysis
Figure 20. Global Cannabis Based Medicines Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cannabis Based Medicines Market Share by Type
Figure 27. Sales Market Share of Cannabis Based Medicines by Type (2020-2025)
Figure 28. Sales Market Share of Cannabis Based Medicines by Type in 2024
Figure 29. Market Size Share of Cannabis Based Medicines by Type (2020-2025)
Figure 30. Market Size Share of Cannabis Based Medicines by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cannabis Based Medicines Market Share by Application
Figure 33. Global Cannabis Based Medicines Sales Market Share by Application (2020-2025)
Figure 34. Global Cannabis Based Medicines Sales Market Share by Application in 2024
Figure 35. Global Cannabis Based Medicines Market Share by Application (2020-2025)
Figure 36. Global Cannabis Based Medicines Market Share by Application in 2024
Figure 37. Global Cannabis Based Medicines Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cannabis Based Medicines Sales Market Share by Region (2020-2025)
Figure 39. Global Cannabis Based Medicines Market Size Market Share by Region (2020-2025)
Figure 40. North America Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Cannabis Based Medicines Sales Market Share by Country in 2024
Figure 43. North America Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cannabis Based Medicines Market Size Market Share by Country in 2024
Figure 45. U.S. Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cannabis Based Medicines Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Cannabis Based Medicines Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cannabis Based Medicines Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cannabis Based Medicines Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Cannabis Based Medicines Sales Market Share by Country in 2024
Figure 53. Europe Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cannabis Based Medicines Market Size Market Share by Country in 2024
Figure 55. Germany Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cannabis Based Medicines Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Cannabis Based Medicines Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cannabis Based Medicines Market Size Market Share by Region in 2024
Figure 68. China Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cannabis Based Medicines Sales and Growth Rate (K Units)
Figure 79. South America Cannabis Based Medicines Sales Market Share by Country in 2024
Figure 80. South America Cannabis Based Medicines Market Size and Growth Rate (M USD)
Figure 81. South America Cannabis Based Medicines Market Size Market Share by Country in 2024
Figure 82. Brazil Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cannabis Based Medicines Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Cannabis Based Medicines Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cannabis Based Medicines Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cannabis Based Medicines Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cannabis Based Medicines Production Market Share by Region (2020-2025)
Figure 103. North America Cannabis Based Medicines Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Cannabis Based Medicines Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Cannabis Based Medicines Production (K Units) Growth Rate (2020-2025)
Figure 106. China Cannabis Based Medicines Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Cannabis Based Medicines Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Cannabis Based Medicines Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Cannabis Based Medicines Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Cannabis Based Medicines Market Share Forecast by Type (2026-2033)
Figure 111. Global Cannabis Based Medicines Sales Forecast by Application (2026-2033)
Figure 112. Global Cannabis Based Medicines Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Cannabis Based Medicines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cannabis Based Medicines Market Size (M USD), 2024-2033
Figure 5. Global Cannabis Based Medicines Market Size (M USD) (2020-2033)
Figure 6. Global Cannabis Based Medicines Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cannabis Based Medicines Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cannabis Based Medicines Product Life Cycle
Figure 13. Cannabis Based Medicines Sales Share by Manufacturers in 2024
Figure 14. Global Cannabis Based Medicines Revenue Share by Manufacturers in 2024
Figure 15. Cannabis Based Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Cannabis Based Medicines Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cannabis Based Medicines Revenue in 2024
Figure 18. Industry Chain Map of Cannabis Based Medicines
Figure 19. Global Cannabis Based Medicines Market PEST Analysis
Figure 20. Global Cannabis Based Medicines Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Cannabis Based Medicines Market Share by Type
Figure 27. Sales Market Share of Cannabis Based Medicines by Type (2020-2025)
Figure 28. Sales Market Share of Cannabis Based Medicines by Type in 2024
Figure 29. Market Size Share of Cannabis Based Medicines by Type (2020-2025)
Figure 30. Market Size Share of Cannabis Based Medicines by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Cannabis Based Medicines Market Share by Application
Figure 33. Global Cannabis Based Medicines Sales Market Share by Application (2020-2025)
Figure 34. Global Cannabis Based Medicines Sales Market Share by Application in 2024
Figure 35. Global Cannabis Based Medicines Market Share by Application (2020-2025)
Figure 36. Global Cannabis Based Medicines Market Share by Application in 2024
Figure 37. Global Cannabis Based Medicines Sales Growth Rate by Application (2020-2025)
Figure 38. Global Cannabis Based Medicines Sales Market Share by Region (2020-2025)
Figure 39. Global Cannabis Based Medicines Market Size Market Share by Region (2020-2025)
Figure 40. North America Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Cannabis Based Medicines Sales Market Share by Country in 2024
Figure 43. North America Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Cannabis Based Medicines Market Size Market Share by Country in 2024
Figure 45. U.S. Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Cannabis Based Medicines Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Cannabis Based Medicines Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Cannabis Based Medicines Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Cannabis Based Medicines Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Cannabis Based Medicines Sales Market Share by Country in 2024
Figure 53. Europe Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Cannabis Based Medicines Market Size Market Share by Country in 2024
Figure 55. Germany Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Cannabis Based Medicines Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Cannabis Based Medicines Sales Market Share by Region in 2024
Figure 67. Asia Pacific Cannabis Based Medicines Market Size Market Share by Region in 2024
Figure 68. China Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Cannabis Based Medicines Sales and Growth Rate (K Units)
Figure 79. South America Cannabis Based Medicines Sales Market Share by Country in 2024
Figure 80. South America Cannabis Based Medicines Market Size and Growth Rate (M USD)
Figure 81. South America Cannabis Based Medicines Market Size Market Share by Country in 2024
Figure 82. Brazil Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Cannabis Based Medicines Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Cannabis Based Medicines Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Cannabis Based Medicines Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Cannabis Based Medicines Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Cannabis Based Medicines Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Cannabis Based Medicines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Cannabis Based Medicines Production Market Share by Region (2020-2025)
Figure 103. North America Cannabis Based Medicines Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Cannabis Based Medicines Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Cannabis Based Medicines Production (K Units) Growth Rate (2020-2025)
Figure 106. China Cannabis Based Medicines Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Cannabis Based Medicines Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Cannabis Based Medicines Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Cannabis Based Medicines Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Cannabis Based Medicines Market Share Forecast by Type (2026-2033)
Figure 111. Global Cannabis Based Medicines Sales Forecast by Application (2026-2033)
Figure 112. Global Cannabis Based Medicines Market Share Forecast by Application (2026-2033)
